Investigation of the molecular mechanism of Xiaoluo Wan in thyroid-associated ophthalmopathy: network analysis and in vivo study. [PDF]
Gu W +5 more
europepmc +1 more source
Histogram of Apparent Diffusion Coefficient to Evaluate the Activity of Thyroid-Associated Ophthalmopathy. [PDF]
Li D, Zhu T, Wang Y.
europepmc +1 more source
Kontroversen in der Behandlung benigner SchilddrĂĽsenerkrankungen [PDF]
Gärtner, Roland +2 more
core
The Value of MRI and Radiomics for the Diagnostic Evaluation of Thyroid-Associated Ophthalmopathy. [PDF]
Zhou W, Song Y, Shi J, Li T.
europepmc +1 more source
Targeted Delivery of CD34 Aptamer-Coupled Tocilizumab Microspheres for Effective Treatment of Thyroid-Associated Ophthalmopathy. [PDF]
Luo Y +8 more
europepmc +1 more source
Retinal and Choroidal Alterations in Thyroid-Associated Ophthalmopathy: A Systematic Review. [PDF]
Ioana AM +3 more
europepmc +1 more source
Application of protein A immunoadsorption in thyroid-associated ophthalmopathy (TAO): study protocol for a non-randomised controlled clinical trial. [PDF]
Lu S, Chen H, Liu S, Zhang F, Xiong W.
europepmc +1 more source
Machine learning unveils hypoxia-immune gene hub for clinical stratification of thyroid-associated ophthalmopathy. [PDF]
Chen L +5 more
europepmc +1 more source
Percutaneous para-levator palpebrae superioris and subconjunctival injection of triamcinolone acetonide for upper eyelid retraction in thyroid-associated ophthalmopathy. [PDF]
Wang M, Luan Y, Qian Z, Wang Y, Fang W.
europepmc +1 more source
LSD1 induces H3 K9 demethylation to promote adipogenesis in thyroid-associated ophthalmopathy. [PDF]
Xu Y +9 more
europepmc +1 more source

